Fullgen is a leading nanobioelectronic detection company launching detection devices based on biosensor technology. These devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across biodetection applications where low power consumption, small size, and ultra-sensitivity offer significant performance advantages and enable unprecedented access to critical information.

Fullgen products:

• Biomolecule Devices
• Biochip Technologies
• Laboratory Products

• A need for immediate access to critical information, to improve public health and safety

• A growing demand for medical point-of-care information.

• The promise of genetics and proteomics to diagnose and treat disease.

• New military and homeland security demands for the detection of chemical and biological warfare agents, and environmental, health and safety regulation.

• A need to simplify complex testing protocols to make them practical for routine use (e.g. clinical diagnostics, point-of-care diagnostics, drug discovery, human identification, personalized therapy, continuous monitoring, biomedical research).